Yüklüyor......
Lurasidone Ingestions Reported to Texas Poison Centers
Background: Lurasidone is an atypical antipsychotic approved for the treatment of schizophrenia in 2010. There is limited information on potentially toxic events involving lurasidone outside of clinical investigations. Objective: This investigation describes potentially toxic lurasidone ingestions f...
Kaydedildi:
| Yayımlandı: | J Pharm Technol |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publications
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5990146/ https://ncbi.nlm.nih.gov/pubmed/34860899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/8755122514533305 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|